NDFS13 Company Presentation: Tangen Biosciences’ Successful Non-Dilutive Funding Journey
John Nobile of Tangen Biosciences talked about his company’s process in achieving their recent contract with BARDA. View Slide Deck
Entries by Ayal Ronen
NDFS13 BARDA Presentation: Partnering with the Biomedical Advanced Research and Development Authority
Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures. View Slide Deck
NDFS13 Company Presentation: Profusa’s Successful Non-Dilutive Funding Journey
Dr. Natalie Wisniewski, of Profusa, Inc., gave some insight about her company’s non-dilutive funding journey, starting with their initial grant from DARPA in 2011 through to today. View Slide Deck
NDFS13 USAMRMC Presentation: Innovative Partnerships with the U.S. Army for Medical Technologies
Dr. James B. Phillips of USAMRMC, Department of Defense, shared with the audience the mission of the US Army Medical Research and Material Command and the Medical Technology Enterprise Consortium, discussing opportunities available for partnering and engaging with Industry. View Slide Deck
NDFS13: FreeMind Group Opening Remarks
Ram May-Ron, Managing Partner of the FreeMind Group, opened the 13th Annual Non-Dilutive Funding Summit with a few comments on the value of non-dilutive funding to the life sciences industry.
‘Twas the night before grant deadline
Adam Ruben doi:10.1126/science.caredit.a1600164 Published online Dec. 21, 2016 in Science Magazine ‘Twas the night before grant deadline, 7:15. Many creatures were stirring, thanks to caffeine. The comments accepted, the references done, In hopes someone might fund my first R01. I wrote like a showman. My prose was terrific. My font was New Roman. My aims […]
Available Online: Medical Device Non-Dilutive Funding: Trends & Opportunities
In a world in which both medical diagnostics and therapies are shifting towards minimally invasive technologies, it is not surprising that steadily increasing non-dilutive funding is available for innovative medical device companies. The scope of funding support covers the entire R&D cycle, from early stage exploratory and discovery work all the way to late stage […]
Available Online: Non-Dilutive Funding for Non-US Applicants
Non-US applicants are eligible for the majority of the non-dilutive pockets of money including NIH, Department of Defense, BARDA etc. Currently, the National Institutes of Health (NIH) are actively funding over 1000 projects in the excess of $1.3B, taking place outside the US and awarded to non-US applicant organizations. And, when taking into account collaborations […]
Life Sciences Summit 2017 – Connecting Innovation, Capital, and Industry
FreeMind is pleased to support the upcoming Life Sciences Summit! Where: New York City, NY When: November 1-2, 2017 The Life Sciences Summit is an early-stage investor and business development conference for emerging companies and academic innovators. The objective of the meeting is to connect emerging companies with early-stage investors, business development professionals, and medical […]